Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS

Overview of attention for article published in Drug Design, Development and Therapy, October 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMPOSITIONS COMPRISING DARUNAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE…

Application WO-2019018676-A1

World Intellectual Property Organisation (WIPO)